… in the present study may be linked to EMT of the tumor cells, with reduced expression of
EpCAM. Furthermore, EpCAM expression on the cell surface may be limited by shedding. Thus, …

… NSCLC with ≥25% tumor cells and urothelial cancer with ≥25% tumor or immune cells
stained for PD-L1 at any intensity were scored PD-L1 positive (PD-L1 + ). Kaplan–Meier and …

… In conclusion the novel Hgf-Cdk4 R24C autochthonous urothelial cancer model and cell lines
… of tumor subtype and biological sex on therapeutic immune modulation in bladder cancer. …

… an immune-suppressive tumor microenvironment [23] (… -cell-mediated immune response to
tumor cells. It is hypothesized that PD-L1 expression on tumor cells and tumor-infiltrating cells …

… of urothelial cancer may require experimental design to address tumor heterogeneity–related …
of tumor cells and their microenvironments (immune cells, fibroblasts, and smooth muscle …

… growth, of a malignant tumor relies on the interaction between tumor cells and their local …
the tumor cells. The grading system reflects the proliferative activity of tumor cells themselves. …

… Interestingly, CD163 expression was observed not only on TAMs but also on tumor cells
in some cases. Moreover, CD163 expression on tumor cells was significantly associated with …

… Different types of whole cells or fragments have been tested, such as tumor cells and
modified autologous cancer or immune cells. Tumor cell vaccines are killed tumor cells injected …

… Though curcumin alone did not alter cell proliferation or apoptosis, tumor cell growth and …
Curcumin-light caused the bladder cancer cells to become arrested in different cell phases: G0/…

… in bladder cancer development and progression. Long non-coding RNA urothelial cancer-associated
1 (lncRNA-UCA1) is highly expressed in bladder cancer tissues and cells, and it …